Cargando…
Treatment success for overactive bladder with urinary urge incontinence refractory to oral antimuscarinics: a review of published evidence
BACKGROUND: Treatment options for overactive bladder (OAB) with urinary urge incontinence (UUI) refractory to oral antimuscarinics include: botulinum toxin type A (BoNTA), sacral neuromodulation (SNM), and augmentation cystoplasty (AC). A standard treatment success metric that can be used in both cl...
Autores principales: | Campbell, Jonathan D, Gries, Katharine S, Watanabe, Jonathan H, Ravelo, Arliene, Dmochowski, Roger R, Sullivan, Sean D |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2788579/ https://www.ncbi.nlm.nih.gov/pubmed/19930578 http://dx.doi.org/10.1186/1471-2490-9-18 |
Ejemplares similares
-
Impact of mirabegron extended-release on the treatment of overactive bladder with urge urinary incontinence, urgency, and frequency
por: Lee, Raymond T, et al.
Publicado: (2013) -
Intradetrusor Injections of Onabotulinum Toxin-A in Children With Urinary Incontinence due to Neurogenic Detrusor Overactivity Refractory to Antimuscarinic Treatment
por: Tarcan, Tufan, et al.
Publicado: (2014) -
Effect of Neuro-Adaptive Electrostimulation Therapy versus Sham for Refractory Urge Urinary Incontinence Due to Overactive Bladder: A Randomized Single-Blinded Trial
por: Zapico, Álvaro, et al.
Publicado: (2023) -
An Overview of the Clinical Use of Antimuscarinics in the Treatment of Overactive Bladder
por: Athanasopoulos, Anastasios, et al.
Publicado: (2011) -
The urinary microbiome in patients with refractory urge incontinence and recurrent urinary tract infection
por: Chen, Zhuoran, et al.
Publicado: (2018)